Inhibition of ATM Induces Hypersensitivity to Proton Irradiation by Upregulating Toxic End Joining
- 16 February 2021
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 81 (12), 3333-3346
- https://doi.org/10.1158/0008-5472.can-20-2960
Abstract
Proton Bragg peak irradiation has a higher ionizing density than conventional photon irradiation or the entrance of the proton beam profile. Whether targeting the DNA damage response could enhance vulnerability to the distinct pattern of damage induced by proton Bragg peak irradiation is currently unknown. Here we performed genetic or pharmacologic manipulation of key DNA damage response elements and evaluated DNA damage signaling, DNA repair, and tumor control in cell lines and xenografts treated with the same physical dose across a radiotherapy linear energy transfer spectrum. Radiotherapy consisted of 6 MV photons and the entrance beam or Bragg peak of a 76.8 MeV spot scanning proton beam. More complex DNA double strand breaks induced by Bragg peak proton irradiation preferentially underwent resection and engaged homologous recombination (HR) machinery. Unexpectedly, the ATM inhibitor AZD0156 but not an inhibitor of ATR rendered cells hypersensitive to more densely ionizing proton Bragg peak irradiation. ATM inhibition blocked resection and shunted more double strand breaks to processing by toxic ligation through nonhomologous end-joining, whereas loss of DNA ligation via XRCC4 or Lig4 knockdown rescued resection and abolished the enhanced Bragg peak cell killing. Proton Bragg peak monotherapy selectively sensitized cell lines and tumor xenografts with inherent HR defects, and the repair defect induced by ATM inhibitor co-administration showed enhanced efficacy in HR proficient models. In summary, inherent defects in HR or administration of an ATM inhibitor in HR proficient tumors selectively enhance the relative biological effectiveness of proton Bragg peak irradiation.Other Versions
Funding Information
- American Society for Radiation Oncology (R01 CA203561)
- NIH (P50CA116201)
- Mayo Clinic (K12 HD065987)
This publication has 62 references indexed in Scilit:
- Deficiency in Homologous Recombination Renders Mammalian Cells More Sensitive to Proton Versus Photon IrradiationInternational Journal of Radiation Oncology*Biology*Physics, 2014
- Dilemmas concerning dose distribution and the influence of relative biological effect in proton beam therapy of medulloblastomaThe British Journal of Radiology, 2012
- Strategies to improve radiotherapy with targeted drugsNature Reviews Cancer, 2011
- The DNA Damage Response: Making It Safe to Play with KnivesMolecular Cell, 2010
- 53BP1 Inhibits Homologous Recombination in Brca1-Deficient Cells by Blocking Resection of DNA BreaksCell, 2010
- Characteristics of DNA-binding proteins determine the biological sensitivity to high-linear energy transfer radiationNucleic Acids Research, 2010
- Human RPA phosphorylation by ATR stimulates DNA synthesis and prevents ssDNA accumulation during DNA-replication stressJournal of Cell Science, 2009
- ATM-Dependent Hyper-Radiosensitivity in Mammalian Cells Irradiated by Heavy IonsInternational Journal of Radiation Oncology*Biology*Physics, 2009
- ATR Affecting Cell Radiosensitivity Is Dependent on Homologous Recombination Repair but Independent of Nonhomologous End JoiningCancer Research, 2004
- A review of dsb induction data for varying quality radiationsInternational Journal of Radiation Biology, 1998